Search research articles
Contact Us
Filters
Showing results (201-210 of 270) with videos related to
Page
of 27
Sort By:
The Journal of Infectious Diseases
|
May 8, 2024
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2
Manish C Choudhary, Rinki Deo, Teresa H Evering, et al.
Open Forum Infectious Diseases
|
March 7, 2024
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy
Cynthia L Gay, Ronald J Bosch, Ashley McKhann, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 29, 2023
High-Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure Due to COVID-19: A Multicenter Phase II Trial
Raffaele Di Fenza, Naman S Shetty, Stefano Gianni, et al.
Biorxiv : the Preprint Server for Biology
|
October 20, 2022
Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1 Omicron
Da-Yuan Chen, Devin Kenney, Chue-Vin Chin, et al.
The New England Journal of Medicine
|
September 16, 2020
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing
Julia Joung, Alim Ladha, Makoto Saito, et al.
JCI Insight
|
February 8, 2024
Predictors of HIV rebound differ by timing of antiretroviral therapy initiation
Jonathan Z Li, Meghan Melberg, Autumn Kittilson, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2026
Post-infection immune response in adults with COVID-19 with and without nirmatrelvir-ritonavir treatment and virologic rebound
Dibya Ghimire, Chloe M Hasund, John Bianchi Colangeli, et al.
Journal of Virology
|
February 4, 2025
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M Ribeiro, Gregory E Edelstein, et al.
Nature
|
January 11, 2023
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation
Da-Yuan Chen, Chue Vin Chin, Devin Kenney, et al.
The Journal of Clinical Investigation
|
July 20, 2018
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers
Radwa Sharaf, Guinevere Q Lee, Xiaoming Sun, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 270) with videos related to
Sort By:
Page
of 27
The Journal of Infectious Diseases
|
May 8, 2024
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2
Manish C Choudhary, Rinki Deo, Teresa H Evering, et al.
Open Forum Infectious Diseases
|
March 7, 2024
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy
Cynthia L Gay, Ronald J Bosch, Ashley McKhann, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 29, 2023
High-Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure Due to COVID-19: A Multicenter Phase II Trial
Raffaele Di Fenza, Naman S Shetty, Stefano Gianni, et al.
Biorxiv : the Preprint Server for Biology
|
October 20, 2022
Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1 Omicron
Da-Yuan Chen, Devin Kenney, Chue-Vin Chin, et al.
The New England Journal of Medicine
|
September 16, 2020
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing
Julia Joung, Alim Ladha, Makoto Saito, et al.
JCI Insight
|
February 8, 2024
Predictors of HIV rebound differ by timing of antiretroviral therapy initiation
Jonathan Z Li, Meghan Melberg, Autumn Kittilson, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2026
Post-infection immune response in adults with COVID-19 with and without nirmatrelvir-ritonavir treatment and virologic rebound
Dibya Ghimire, Chloe M Hasund, John Bianchi Colangeli, et al.
Journal of Virology
|
February 4, 2025
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M Ribeiro, Gregory E Edelstein, et al.
Nature
|
January 11, 2023
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation
Da-Yuan Chen, Chue Vin Chin, Devin Kenney, et al.
The Journal of Clinical Investigation
|
July 20, 2018
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers
Radwa Sharaf, Guinevere Q Lee, Xiaoming Sun, et al.
Page
of 27